Serum hyaluronic acid: A promising marker of hepatic fibrosis in chronic hepatitis B

Serum hyaluronic acid: A promising marker of hepatic fibrosis in chronic hepatitis B

Bibliographic Details
Main Author:	Shiha Gamal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2008-01-01
Series:	The Saudi Journal of Gastroenterology
Online Access:	http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2008;volume=14;issue=4;spage=161;epage=162;aulast=Shiha

Similar Items

Hyaluronic Acid act as a Non - Invasive Marker for Diagnosis of Liver Fibrosis in the Patients of Chronic Hepatitis C
by: Muhammad Akram, et al.
Published: (2018-09-01)

Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B
by: Tugrul Purnak, et al.
Published: (2012-06-01)

Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis
by: Kei Moriya, et al.
Published: (2021-06-01)

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
by: Hyo Jung Cho, et al.
Published: (2014-12-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Current status and future directions in the management of chronic hepatitis C
by: Aman Wosen, et al.
Published: (2012-03-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)

Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients
by: Clarice Neuenschwander Lins de Morais, et al.
Published: (2010-07-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
by: Nana Zhang, et al.
Published: (2023-02-01)

Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels
by: Lin Wang, et al.
Published: (2023-07-01)

Preparation of Phillygenin-Hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect
by: Lihong Gong, et al.
Published: (2023-12-01)

A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy
by: Avick Nag, et al.
Published: (2024-02-01)

Effect of viral load on hepatic fibrosis in patients with chronic hepatitis B patients: assessed by fibroscan
by: Usama M. Abdelaal*, et al.
Published: (2023-07-01)

Reliability of Hepatus® for Evaluating Liver Fibrosis in Chronic Hepatitis B
by: Jessica Cynthia Febryani, et al.
Published: (2022-09-01)

Serum Procalcitonin Levels in Chronic Hepatitis B Infection
by: Süda TEKİN KORUK, et al.
Published: (2011-09-01)

Serum Alpha-Fetoprotein as a Predictor of Liver Fibrosis in HBeAg-Positive Chronic Hepatitis B Patients
by: Kai Yang, et al.
Published: (2023-05-01)

The using of genetic markers as a possibility of predicting the rate of progress of liver fibrosis in patients with chronic hepatitis B
by: К.М. Usychenko
Published: (2023-09-01)

Staging Fibrosis in Chronic Viral Hepatitis
by: Ana Carolina Cardoso, et al.
Published: (2022-03-01)

Perivenular fibrosis in chronic HCV hepatitis.
by: Kennedy, M, et al.
Published: (1999)

Perivenular fibrosis in chronic HCV hepatitis.
by: Kennedy, M, et al.
Published: (1998)

Relationship of hemogram and biochemical parameters with modified histologic activity index and hepatic fibrosis in chronic hepatitis B
by: Selma Erdoğan Düzcü, et al.
Published: (2021-09-01)

Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis
by: Laura Pandolfi, et al.
Published: (2021-07-01)

Assessment of Noninvasive Methods for Prediction of Fibrosis in Patients with Chronic Hepatitis B
by: Cemal BULUT, et al.
Published: (2007-09-01)

Opium Consumption and Risk of Liver Fibrosis in Chronic Hepatitis B and C
by: Ahmad Shavakhy, et al.
Published: (2010-11-01)

Prevalence and Risk Factors of Hepatitis B Serum Marker in Patients with Chronic Kidney Failure undergoing Haemodialysis
by: Khansa Khalil, et al.
Published: (2018-11-01)

Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
by: Cheng-Hao Tseng, et al.
Published: (2018-10-01)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.
by: Mette J Nielsen, et al.
Published: (2015-01-01)

Shedding light on the “gray zone”: Hepatic fibrosis in chronic hepatitis B patients with fluctuating HBV DNA levels
by: Andrew Brown, et al.
Published: (2022-01-01)

Comparison of diagnostic informative value of the methods for the determination of direct (hyaluronic acid) and indirect (alanine aminotransferase, aspartate aminotransferase, de Rithis coefficient) of liver fibrosis markers in patients with chronic viral hepatitis C
by: L. V. Moroz, et al.
Published: (2019-05-01)

Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa
by: Asgeir Johannessen, et al.
Published: (2023-01-01)

Keratin 18 phosphorylation as a progression marker of chronic hepatitis B
by: Wu Hao, et al.
Published: (2010-03-01)

Assessment of compensated advanced chronic liver disease based on serum bile acids in chronic hepatitis B patients
by: Fei Chen, et al.
Published: (2023-08-01)

Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America
by: Hin Hin Ko, et al.
Published: (2022-01-01)

Correction: Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
by: Phaedra M Tachtatzis, et al.
Published: (2015-01-01)

Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients
by: Viva Finhar Insani Nirmala, et al.
Published: (2023-04-01)

Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections
by: Yang Shi, et al.
Published: (2023-05-01)

ENDOTHELIUM LESION MARKERS AND THROMBOCYTE AGGREGATION IN CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS
by: A. P. Shchekotova
Published: (2014-07-01)